VITASPRING BIOMEDICAL CO. LTD. (VSBC) stock: key figures, P/E, revenue and dividend

Industrials · United States · ISIN US92851B1026

Price
0.02 USD
Market cap
3.21 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
9.38 %
Return on assets (ROA)
-2,830.25 %

VITASPRING BIOMEDICAL CO. LTD. financials

Fiscal year20252026
Revenue0.00 USD0.00 USD
Gross profit0.00 USD0.00 USD
Operating income-679,914.00 USD-385,411.00 USD
EBIT-679,914.00 USD-385,411.00 USD
Net income-774,922.00 USD-415,368.00 USD
Diluted EPS – continuing operations0.00 USD0.00 USD

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About VITASPRING BIOMEDICAL CO. LTD.

VitaSpring Biomedical Co. Ltd., a development-stage biomedical company, engages in the research, development, and commercialization of wellness and healthy lifestyle products. It focuses on the development of cell-based medical technologies for use in regenerative medicine, preventive health care, beauty, and anti-aging applications. The company is also involved in the development of cell medical treatment. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is based in Riverside, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.